Skip to main content
SpringerLink
Log in

Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Diabetes may modify central nervous system functions and is associated with moderate cognitive deficits and changes in the brain, a condition that may be referred to as diabetic encephalopathy. The prevalence of depression in diabetic patients is higher than in the general population, and clonazepam is being used to treat this complication. Oxidative stress may play a role in the development of diabetes complications. We investigated oxidative stress parameters in streptozotocin-induced diabetic rats submitted to forced swimming test (STZ) and evaluated the effect of insulin (STZ-INS) and/or clonazepam (STZ-CNZ and STZ-INS-CNZ) acute treatment on these animal model. Oxidative damage to proteins measured as carbonyl content in plasma was significantly increased in STZ group compared to STZ treated groups. Malondialdehyde plasma levels were significantly reduced in STZ-INS and STZ-INS-CNZ groups when compared to STZ rats, being significantly reduced in STZ-INS-CNZ than STZ-INS rats. The activities of the antioxidant enzymes catalase, superoxide dismutase and glutathione peroxidase showed no significant differences among all groups of animals. These findings showed that protein and lipid damage occurs in this diabetes/depression animal model and that the associated treatment of insulin and clonazepam is capable to protect against oxidative damage in this experimental model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126

    Article  PubMed  CAS  Google Scholar 

  • Ahmed RG (2005) The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system. Med J Islamic World Acad Sci 15(1):31–42

    Google Scholar 

  • American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diab Care 32(suppl 1):s62–s67

    Article  Google Scholar 

  • Artola A (2008) Diabetes-, stress- and ageing-related changes in synaptic plasticity in hippocampus and neocortex—the same metaplastic process? Eur J Pharmacol 585:153–162

    Article  PubMed  CAS  Google Scholar 

  • Balkis SB, Fadilah RN, Ezlan A, Khairul O, Mokhtar AB, Jamaludin M (2008) Oxidative stress and DNA damage in streptozotocin-induced diabetic rats: effects of alpha lipoic acid. J Biol Sci 8(3):622–627

    Article  CAS  Google Scholar 

  • Bhatia S, Shukla R, Venkata MS, Kaur GJ, Madhava PK (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36:557–562

    Article  PubMed  CAS  Google Scholar 

  • Biessels GJ, Van Der Heide LP, Kamal A, Bleys RL, Gispen WH (2002) Aging and diabetes: implications for brain function. Eur J Pharmacol 441:1–14

    Article  PubMed  CAS  Google Scholar 

  • Bonnefont-Rousselot D, Beaudeux JL, Therond P, Peynet J, Legrand A, Delattre J (2004) Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 62:147–157

    PubMed  CAS  Google Scholar 

  • Borowicz KK, Luszczki J, Szadkowski M, Kleinrok Z, Czuczwar SJ (1999) Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Eur J Pharmacol 10:67–72

    Article  Google Scholar 

  • Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820

    Article  PubMed  CAS  Google Scholar 

  • Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625

    Article  PubMed  CAS  Google Scholar 

  • Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557

    Article  PubMed  CAS  Google Scholar 

  • Chevassus H, Mourand I, Molinier N, Lacarelle B, Brun JF, Petit P (2004) Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-bind, placebo-controlled, randomized cross-over trial. BMC Clin Pharmacol 4:3

    Article  PubMed  Google Scholar 

  • Contreras CM, Martínez-Mota L, Saavedra M (1998) Desipramine restricts estral cycle oscillations in swimming. Prog Neuropsychopharmacol Biol Psychiatry 22(7):1121–1128

    Article  PubMed  CAS  Google Scholar 

  • Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52(4):601–623

    Article  PubMed  CAS  Google Scholar 

  • Duarte AI, Santos MS, Seica R, Oliveira CR (2004) Oxidative stress affects synaptosomal gamma-aminobutyric acid and glutamate transport in diabetic rats: the role of insuline. Diabetes 53(8):2110–2116

    Article  PubMed  CAS  Google Scholar 

  • Gomez R, Barros HMT (2000) Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol Biochem Behav 66:329–335

    Article  PubMed  CAS  Google Scholar 

  • Guyot LL, Diaz FG, O’regan MH, Song D, Phillis JW (2001) The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 48:385–391

    Article  PubMed  CAS  Google Scholar 

  • Haeser AS, Sitta A, Barschak AG, Deon M, Barden AT, Schmitt GO, Landgraff S, Gomez R, Barros HMT, Vargas CR (2007) Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect. Brain Res 1154:335–338

    Article  Google Scholar 

  • Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685–716

    Article  PubMed  CAS  Google Scholar 

  • Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Oxford University Press, New York, p 936

    Google Scholar 

  • Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231–255

    Article  PubMed  CAS  Google Scholar 

  • Harvey BH (2008) Is major depressive disorder a metabolic encephalopathy? Hum. Psychopharmacol 23:371–384

    Article  Google Scholar 

  • Hilakivi-Clarke LA, Wozniak KM, Durcan MJ, Linnoila M (1990) Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol Behav 48:429–433

    Article  PubMed  CAS  Google Scholar 

  • Imaeda V, Aoki T, Kondo Y, Hori M, Ogata M, Obayashi H, Hasegawa G, Nakamura N, Tokuda K, Nishino H, Yoshikawa T, Kondo M (2001) Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis. Free Radic Res 34(1):33–44

    Article  PubMed  CAS  Google Scholar 

  • Imaeda A, Kaneko T, Aoki T, Kondo Y, Nagase H (2002) DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol 40(7):979–987

    Article  PubMed  CAS  Google Scholar 

  • Kalousova M, Skrha J, Zima T (2002) Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604

    PubMed  CAS  Google Scholar 

  • Kamalakkannan N, Prince PS (2003) Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats. J Ethnopharmacol 87(2–3):207–210

    Article  PubMed  CAS  Google Scholar 

  • Karatepe M (2004) Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC-UV. LCGC North Am 22:362–365

    CAS  Google Scholar 

  • Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transplant 13:2829–2832

    Article  PubMed  CAS  Google Scholar 

  • Kocic R, Pavlovic D, Kocic G (2007) Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus. Vojnosanit Pregl 64(9):623–628

    PubMed  Google Scholar 

  • Kuhad A, Chopra K (2009) Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci 27;84(9–10):296–301

    Google Scholar 

  • Laron Z (2009) Insulin and the brain. Arch Physiol Biochem 2; 115 (2):112–116

    Google Scholar 

  • Levine RL, Garland D, Oliver CN, Amici A, Climent L, Lenz AG, Ahn BW, Shalthiel S, Stadman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186:464–478

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  • Maritim AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38

    Article  PubMed  CAS  Google Scholar 

  • McCaffery JM, Niaura R, Todaro JF, Swan GE, Carmelli D (2003) Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute Twin Study. Psychosom Med 65:490–497

    Article  PubMed  Google Scholar 

  • Miles WR, Root HF (1922) Psychologic tests applied to diabetic patients. Arch Int Med 30:767–777

    Google Scholar 

  • Monnier L, Colette C, Mas E, Michel F, Cristol JP, Boegner C, Owens DR (2009) Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 53(3):562–571

    Article  PubMed  Google Scholar 

  • Morishita S (2009) Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review. Hum Psychipharmacol Clin Exp 24:191–198

    Article  CAS  Google Scholar 

  • Paglia DE, Valentine WN (1967) Glutathione peroxidase. J Lab Clin Med 70:158

    PubMed  CAS  Google Scholar 

  • Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551

    Article  PubMed  Google Scholar 

  • Pearce DA, Atkinson M, Tagle DA (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63(11):2001–2005

    PubMed  CAS  Google Scholar 

  • Piwowar A, Knapik-Kordecka M, Szczecin’ska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553

    Article  PubMed  CAS  Google Scholar 

  • Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new model sensitive to antidepressant treatment. Nature 266:730–732

    Article  PubMed  CAS  Google Scholar 

  • Rajtar G, Zolkowska D, Keinrok Z (2002) Effect of diazepam and clonazepam on the function of isolated rat platelet and neutrophils. Intern Med J Exp Clin Res 8(4):37–44

    Google Scholar 

  • Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2:22

    Article  PubMed  Google Scholar 

  • Sadi G, Yimaz O, Güray T (2008) Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase. Mol Cell Biochem 309(1–2):109–116

    Article  PubMed  CAS  Google Scholar 

  • Sanvitto GL, Barros HM, Ribeiro MF, Marques M (1992) Decreased specific insulin binding to hypothalamus from rats submitted to Porsolt’s swimm test. Med Sci Res 20:699–700

    CAS  Google Scholar 

  • Sasvári M, Nyakas C (2003) Time dependent changes in oxidative metabolism during chronic diabetes in tars. Acta Biol Szegediensis 47(1):153–158

    Google Scholar 

  • Sies H (1991) Oxidative stress: Oxidants and antioxidants. Academic, New York

    Google Scholar 

  • Sima AA, Kamiya H, Li ZG (2004) Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 490:187–197

    Article  PubMed  CAS  Google Scholar 

  • Stetina R, Varvarovska J, Rusavy Z, Pomahacova R, Racek J, Lacigová S, Trefil L, Siala K, Stozicky F (2006) Oxidative stress, DNA damage and DNA repair capacity in children with type 1 diabetes mellitus. Toxicol Lett 164(suppl):S1–S134

    Google Scholar 

  • Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112

    Article  PubMed  CAS  Google Scholar 

  • Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diab Care 20:438–445

    Article  CAS  Google Scholar 

  • Suarez EC (2006) Sex differences in the relation of depressive symptoms, hostility, and anger expression indices of glucose metabolism in nondiabetics. Health Psychol 25:484–492

    Article  PubMed  Google Scholar 

  • Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 4:255–260

    Google Scholar 

  • Tsigos C, Chrousos GP (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–871

    Article  PubMed  Google Scholar 

  • Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW (2007) Hypercortisolemic depression is associtated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32:151–159

    Article  PubMed  CAS  Google Scholar 

  • Wiernsperger NF (2003) Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 29:579–585

    Article  PubMed  CAS  Google Scholar 

  • Witko-Sarsat V, Friedlander M, Khoa TN, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from CAPES, CNPq and FIPE/HCPA-Brazil.

Conflict of interest disclosure

The authors declare that there is no conflict of interest disclosure associated with this manuscript.

Author information

Authors and Affiliations

  1. Programa de Pós-Graduação em Ciências Farmacêuticas, Porto Alegre, RS, Brazil

    Carlos Alberto Yasin Wayhs, Vanusa Manfredini, Graziela Ribas & Carmen Regla Vargas

  2. Serviço de Genética Médica, HCPA, Rua Ramiro Barcelos, 2350, CEP 90.035-903, Porto Alegre, RS, Brazil

    Carlos Alberto Yasin Wayhs, Vanusa Manfredini, Angela Sitta, Marion Deon, Graziela Ribas, Camila Vanzin, Giovana Biancini & Carmen Regla Vargas

  3. Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, UFRGS, Porto Alegre, RS, Brazil

    Angela Sitta & Carmen Regla Vargas

  4. Departamento de Farmacologia, UFCSPA, Porto Alegre, RS, Brazil

    Marcelo Ferri, Maurício Nin & Helena Maria Tannhauser Barros

Authors
  1. Carlos Alberto Yasin Wayhs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanusa Manfredini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Sitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marion Deon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Graziela Ribas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Camila Vanzin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giovana Biancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marcelo Ferri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maurício Nin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Helena Maria Tannhauser Barros
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Carmen Regla Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Carlos Alberto Yasin Wayhs or Carmen Regla Vargas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wayhs, C.A.Y., Manfredini, V., Sitta, A. et al. Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect. Metab Brain Dis 25, 297–304 (2010). https://doi.org/10.1007/s11011-010-9211-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-010-9211-0

Keywords

Search

Navigation